Baxter International (BAX) | Stock Overview & Key Data
Baxter International Performance Comparison
Stock Range
Today's Range
Low: $23.28
High: $23.86
on August 8, 2025
52 Week Range
Low: $21.33
High: $40.49
on August 1, 2025
on September 17, 2024
All-Time High: $95.19 on April 20, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$11.6B
EPS
-0.48
P/E Ratio (TTM)
86.31
Forward P/E
7.81
P/B Ratio
1.63
PEG Ratio
7.81
Div. Yield
1.99%
ROE
-9.24%
Beta
0.591
Debt to Equity
146.14
Financial Highlights
Profitability
Gross Margin
35.27%
Operating Margin
7.58%
Profit Margin
-1.42%
Returns and Earnings
Return on Assets (TTM)
-2.52%
Return on Equity (TTM)
-9.24%
EBITDA
$1.5B
Net Income (TTM)
$-247.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$21.31
Quarterly Revenue Growth (YoY)
7.05%
Quarterly Earnings Growth (YoY)
-26.29%
Dividend Information
Last 12-Month Dividend
$0.63
Current Dividend Yield
1.99%
3-Year Average Dividend Yield
0.66%
3-Year Average Annual Dividend
$0.89
3-Year Total Dividends
$2.66
Ex-Dividend Date
February 28, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Baxter International BAX | 11.56B Large-cap | 8.18% | -20.71% | -23.37% | -23.12% | -19.55% | -36.64% | -61.07% | -71.81% |
| Intuitive Surgical ISRG | 173.27B Large-cap | -2.34% | -12.14% | -12.37% | -19.41% | -10.35% | 2.29% | 98.88% | 107.77% |
| Becton, Dickinson BDX | 53.31B Large-cap | 5.29% | 8.52% | 12.29% | -18.35% | -17.14% | -20.44% | -28.83% | -25.49% |
| Alcon ALC | 45.84B Large-cap | -2.40% | -1.56% | -11.08% | -4.59% | 2.40% | -8.04% | 21.95% | 38.88% |
| ResMed RMD | 42.73B Large-cap | 3.03% | 9.27% | 14.50% | 18.25% | 22.62% | 29.49% | 16.86% | 58.65% |
| West Pharmaceutical WST | 17.14B Large-cap | 0.53% | 8.61% | 12.85% | -25.19% | -26.75% | -17.57% | -30.41% | -12.92% |
Ownership & Short Interest
Insider Ownership
0.29%
Institutional Ownership
98.58%
Shares Short
18M
Short Ratio
4.28
Short % of Shares Outstanding
5.39%
Average 10-Day Volume
14M
Average 90-Day Volume
8M
Baxter International Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Baxter International would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BAX's 52-week high and low?
- In the last 52 weeks, Baxter International reached a high of $40.49 (on September 17, 2024) and a low of $21.33 (on August 1, 2025).
- What is the market cap and P/E ratio for BAX?
- Curious about Baxter International's size and valuation? Its market capitalization stands at 11.56B. When it comes to valuation, the P/E ratio (trailing twelve months) is 86.31, and the forward P/E (looking ahead) is 7.81.
- Does BAX pay dividends? If so, what's the yield?
- Yes, Baxter International is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.99%, and the company has paid an average of $0.89 per share annually over the past 3 years.
- Who are Baxter International's main competitors or similar companies to consider before investing?
When looking at Baxter International, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG173.27B Healthcare Medical Instruments & Supplies 2.29% 98.88% Becton, Dickinson
BDX53.31B Healthcare Medical Instruments & Supplies -20.44% -28.83% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -8.04% 21.95% ResMed
RMD42.73B Healthcare Medical Instruments & Supplies 29.49% 16.86% West Pharmaceutical
WST17.14B Healthcare Medical Instruments & Supplies -17.57% -30.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Baxter International Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Baxter International's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -9.24%, the Debt to Equity ratio from the most recent quarter is 146.14, and its Gross Profit Margin stands at 35.27%.
- What is the recent revenue and earnings growth for BAX?
- Looking at Baxter International's growth, its revenue over the trailing twelve months (TTM) was $11B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.05%, and quarterly earnings saw a YoY growth of -26.29%.
- How much of BAX stock is held by insiders and institutions?
- Wondering who owns Baxter International stock? Company insiders (like executives and directors) hold about 0.29% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 98.58%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.